Results 261 to 267 of about 41,565 (267)

Previous treatment influences fingolimod efficacy in relapsing–remitting multiple sclerosis: results from an observational study

Current Medical Research and Opinion, 2014
Erica Curti, Sara Montepietra, Anna Maria Simone   +2 more
exaly  

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

Therapeutic Advances in Neurological Disorders, 2011
Bernard M J Uitdehaag, Cris S Constantinescu, Douglas Jeffery   +2 more
exaly  

Cortical thickness and surface area relate to specific symptoms in early relapsing–remitting multiple sclerosis

Multiple Sclerosis Journal, 2015
Kristine B Walhovd, Piotr Sowa, Atle Bjørnerud   +2 more
exaly  

Effects of fingolimod in relapsing-remitting multiple sclerosis

The Lancet Neurology, 2014
openaire   +3 more sources

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

Multiple Sclerosis Journal, 2018
Gavin Giovannoni, Per Soelberg Sørensen, Stuart Cook   +2 more
exaly  

Effect of high-dose vitamin D 3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal, 2017
Andreas Lossius, Nada Abdelmagid, Jonas C Lindstrøm   +2 more
exaly  

Relapsing–Remitting Multiple Sclerosis

2011
openaire   +1 more source